Skip to content Menu
Science Chronicle

Science Chronicle

A Science and Technology Blog

Sidebar
  • Home
  • PODCASTS
  • About
  • ARCHIVES
  • Award for R. Prasad

Category: Medicines & Healthcare products Regulatory Agency (MHRA)

Posted on January 15, 2021January 15, 2021

Vaccine dilemma: To take or not to take Covaxin

True, in the U.S., vaccines from both Pfizer and Moderna are available and recipients, who are health-care workers and nursing home residents, have no option to choose the vaccine. In…

Continue Reading
Posted on January 2, 2021

UK uses an untested strategy to rapidly but partially protect people at risk

With the virus running amok in the country and vaccines in short-supply, the U.K. is attempting an untested strategy of delaying the second dose of both AstraZeneca and Pfizer vaccine even in the absence of data from large trials. The intent is to rapidly but partially protect more individuals who are at risk.

Continue Reading
Follow Science Chronicle on WordPress.com

Enter your email address to follow this blog and receive notifications of new posts by email.

Join 10,581 other followers

Archives

Social

  • View Prasad.Ravindranath’s profile on Facebook
  • View @RPrasad12’s profile on Twitter
  • View Prasad.Ravindranath@gmail.com’s profile on Google+

Recent Posts

  • Indian scientists divided over restricted use approval for Covaxin January 15, 2021
  • Vaccine dilemma: To take or not to take Covaxin January 15, 2021
  • Serious violations in Covaxin trial in Bhopal show nothing has changed since the egregious HPV vaccine trial January 13, 2021
  • New challenges in conducting COVID-19 vaccine trials in India January 9, 2021
  • I would not take Covaxin without efficacy data: Gagandeep Kang January 8, 2021

Most Read Posts

  • Vaccine dilemma: To take or not to take Covaxin
  • Indian scientists divided over restricted use approval for Covaxin
  • Serious violations in Covaxin trial in Bhopal show nothing has changed since the egregious HPV vaccine trial
  • I would not take Covaxin without efficacy data: Gagandeep Kang
  • 'Serum’s pneumococcal vaccine will be available by June 2020'
  • India's TB control programme renamed to reflect its intent on ending TB
  • No correlation between Ct values of PCR test and COVID-19 severity
  • Home
  • PODCASTS
  • About
  • ARCHIVES
  • Award for R. Prasad
  • Home
  • PODCASTS
  • About
  • ARCHIVES
  • Award for R. Prasad
Create a website or blog at WordPress.com
Top
Follow Science Chronicle on WordPress.com

Enter your email address to follow this blog and receive notifications of new posts by email.

Join 10,581 other followers

Archives